Table 1.
The correlations of Glo1 with clinicopathological features of breast cancer patients
| Clinicopathologic Variable | n | GLO1 expression | P | |
|---|---|---|---|---|
|
| ||||
| Low | High | |||
| Age (year) | ||||
| ≤45 | 35 | 14 | 21 | |
| >45 | 86 | 37 | 49 | 0.760 |
| Histological grade | ||||
| I | 30 | 13 | 17 | |
| II-III | 91 | 38 | 53 | 0.880 |
| Positive lymph node | ||||
| ≤3 | 83 | 44 | 39 | |
| >3 | 38 | 7 | 31 | <0.001 |
| Lymphovascular invasion | ||||
| Absence | 73 | 40 | 33 | |
| Presence | 48 | 11 | 37 | <0.001 |
| Tumor size (cm) | ||||
| ≤2 | 30 | 14 | 16 | |
| >2 | 91 | 37 | 54 | 0.563 |
| ER | ||||
| Positive | 83 | 39 | 44 | |
| Negative | 38 | 12 | 26 | 0.111 |
| PR | ||||
| Positive | 57 | 22 | 35 | |
| Negative | 64 | 29 | 35 | 0.455 |
| Her2 | ||||
| Negative | 67 | 31 | 36 | |
| Positive | 54 | 20 | 34 | 0.307 |
| TNM stage | ||||
| I-II | 79 | 43 | 36 | |
| III | 42 | 8 | 34 | <0.001 |
Abbreviations: ER, estrogen receptor; PR, progesterone receptor; Her2, Human Epidermal Growth Factor Receptor type 2; TNM, tumor node metastasis.